FDA updates labeling for FENTANYL CITRATE
Labeling changes approved for EXELA PHARMA. Active ingredient: FENTANYL CITRATE. Decision date: 12/22/2025
Labeling changes approved for EXELA PHARMA. Active ingredient: FENTANYL CITRATE. Decision date: 12/22/2025
There are no comments here yet...